Zusammenfassung
Störungen im glucotropen Regelkreis führen zu einem Typ-2-Diabetes mellitus (T2DM). Neben der peripheren Insulinresistenz trägt zur Manifestation eine gestörte Insulinsekretion durch Dysfunktion der β-Zellen des Pankreas bei. β-Zellen messen durch Expression des Sensorproteins Glucokinase die Glucosekonzentration im Blut und passen dadurch die Insulinsekretion an den Ernährungszustand an. Eine regulierte Insulinfreisetzung in Abhängigkeit vom wechselnden Substratangebot an Kohlenhydraten, Fetten und Proteinen ist für die Glucosehomöostase des Blutes sowie den Energiemetabolismus der Zellen essenziell und gerät durch Überalimentation aus dem Gleichgewicht. Mitochondrien sind die zentrale Schaltstelle für die bedarfsgerechte Bereitstellung der zellulären Energie. Für ihre Funktion ist ihre morphologische Struktur essenziell. Diese ist mitnichten starr, sondern hochdynamisch. Mitochondrien bilden in β-Zellen ein tubuläres Netzwerk, das durch ständige Fusions- und Teilungsprozesse aufrechterhalten wird. Geraten diese Prozesse unter Bedingungen eines Überangebots an Glucose und Fetten aus dem Gleichgewicht, begünstigt diese mitochondriale Dysfunktion einen T2DM.
Abstract
Glucose intolerance is the major cause of type 2 diabetes mellitus (T2DM). In addition to peripheral insulin resistance, pancreatic beta cell dysfunction with reduced insulin secretion contributes to T2DM manifestation. The glucose sensor enzyme glucokinase is the key regulator in beta cells coupling an increase in blood glucose to insulin secretion. This demand-based insulin secretion is important for blood glucose homeostasis and cellular energy metabolism despite changing substrate availability from carbohydrates, fat and proteins. Supernutrition induces an imbalance in this control loop. Mitochondria are the pivotal organelles of cellular energy. The mitochondrial morphology is crucial to maintain their function and is by no means fixed but highly dynamic. Mitochondria form a tubular network in β-cells, which frequently undergoes fusion and fission events. Hyperglycemia and hyperlipidemia promote maladjustment of the mitochondrial network, thus contributing to mitochondrial dysfunction and promoting T2DM.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-014-1278-5/MediaObjects/11428_2014_1278_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-014-1278-5/MediaObjects/11428_2014_1278_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-014-1278-5/MediaObjects/11428_2014_1278_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-014-1278-5/MediaObjects/11428_2014_1278_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-014-1278-5/MediaObjects/11428_2014_1278_Fig5_HTML.jpg)
Literatur
Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083
Haataja L, Gurlo T, Huang CJ et al (2008) Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 29:303–316
Florez JC, Hirschhorn J, Altshuler D (2003) The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet 4:257–291
Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92:707–715
Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207
Pal A, McCarthy MI (2013) The genetics of type 2 diabetes and its clinical relevance. Clin Genet 83:297–306
Donath MY, Schumann DM, Faulenbach M et al (2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2):161–164
Tiedge M, Lortz S, Drinkgern J et al (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733–1742
Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42–61
Jin W, Patti ME (2009) Genetic determinants and molecular pathways in the pathogenesis of type 2 diabetes. Clin Sci 116:99–111
Gallagher EJ, Leroith D, Karnieli E (2010) Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 77:511–523
Jung HS, Lee MS (2010) Role of autophagy in diabetes and mitochondria. Ann N Y Acad Sci 1201:79–83
Nolan CJ, Madiraju MS, Delghingaro-Augusto V et al (2006) Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 55(Suppl 2):16–23
Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366
Newsholme P, Haber EP, Hirabara SM et al (2007) Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 583:9–24
Takahashi HK, Santos LR, Roma LP et al (2014) Acute nutrient regulation of the mitochondrial glutathione redox state in pancreatic beta-cells. Biochem J 460:411–423
El-Assaad W, Joly E, Barbeau A et al (2010) Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832/13 ss-cells. Endocrinology 151:3061–3073
Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442
Baltrusch S, Tiedge M (2006) Glucokinase regulatory network in pancreatic beta-cells and liver. Diabetes 55(Suppl 2):55–64
Schuit F, De Vos A, Farfari S et al (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272:18572–18579
Prentki M, Tornheim K, Corkey BE (1997) Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 40(Suppl 2):32–41
Maechler P (2002) Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic beta-cells. Cell Mol Life Sci 59:1803–1818
Wiederkehr A, Wollheim CB (2012) Mitochondrial signals drive insulin secretion in the pancreatic β-cell. Mol Cell Endocrinol 353:128–137
Henquin JC (2009) Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 52:739–751
Kim JW, Yoon KH (2011) Glucolipotoxicity in pancreatic beta-cells. Diabetes Metab J 35:444–450
Poitout V, Amyot J, Semache M et al (2010) Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801:289–298
Chawla A, Nguyen KD, Goh YP (2011) Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 11:738–749
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
Johnson DC, Dean DR, Smith AD et al (2005) Structure, function, and formation of biological iron-sulfur clusters. Annu Rev Biochem 74:247–281
Scheffler IE (2001) Mitochondria make a come back. Adv Drug Deliv Rev 49:3–26
Liu X, Kim CN, Yang J et al (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157
Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205–219
Chen XJ, Butow RA (2005) The organization and inheritance of the mitochondrial genome. Nat Rev Genet 6:815–825
Anderson S, Bankier AT, Barrell BG et al (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457–465
Croteau DL, Bohr VA (1997) Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272:25409–25412
Maassen JA, Janssen GM, ‚t Hart LM (2005) Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 37:213–221
Wallace DC (1997) Mitochondrial DNA in aging and disease. Sci Am 277:40–47
Beckman KB, Ames BN (1998) Mitochondrial aging: open questions. Ann N Y Acad Sci 854:118–127
Bensch KG, Mott JL, Chang SW et al (2009) Selective mtDNA mutation accumulation results in beta-cell apoptosis and diabetes development. Am J Physiol Endocrinol Metab 296:E672–E680
Maassen JA, ‚t Hart LM, Van Essen E et al (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1):103–109
Weiss H, Wester-Rosenloef L, Koch C et al (2012) The mitochondrial Atp8 mutation induces mitochondrial ROS generation, secretory dysfunction, and beta-cell mass adaptation in conplastic B6-mtFVB mice. Endocrinology 153:4666–4676
Bereiter-Hahn J, Vöth M (1994) Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 27:198–219
Rizzuto R, Brini M, De Giorgi F et al (1996) Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo. Curr Biol 6:183–188
Chen H, Chan DC (2005) Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet 14:R283–R289
Liesa M, Palacín M, Zorzano A (2009) Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89:799–845
Smirnova E, Griparic L, Shurland DL et al (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12:2245–2256
Chen H, Detmer SA, Ewald AJ et al (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160:189–200
Wikstrom JD, Twig G, Shirihai OS (2009) What can mitochondrial heterogeneity tell us about mitochondrial dynamics and autophagy? Int J Biochem Cell Biol 41:1914–1927
Ono T, Isobe K, Nakada K et al (2001) Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat Genet 28:272–275
Busch KB, Bereiter-Hahn J, Wittig I et al (2006) Mitochondrial dynamics generate equal distribution but patchwork localization of respiratory Complex I. Mol Membr Biol 23:509–520
Twig G, Hyde B, Shirihai OS (2008) Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta 1777:1092–1097
Twig G, Elorza A, Molina AJ et al (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27:433–446
Catlett NL, Weisman LS (2000) Divide and multiply: organelle partitioning in yeast. Curr Opin Cell Biol 12:509–516
Bach D, Pich S, Soriano FX et al (2003) Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278:17190–17197
Tanaka A, Cleland MM, Xu S et al (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191:1367–1380
Zorzano A, Liesa M, Sebastián D et al (2010) Mitochondrial fusion proteins: dual regulators of morphology and metabolism. Semin Cell Dev Biol 21:566–574
Chen H, Chomyn A, Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280:26185–26192
Santel A, Frank S, Gaume B et al (2003) Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 116:2763–2774
Ranieri M, Brajkovic S, Riboldi G et al (2013) Mitochondrial fusion proteins and human diseases. Neurol Res Int 2013:293893
Ishihara N, Fujita Y, Oka T et al (2006) Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 25:2966–2977
Head B, Griparic L, Amiri M et al (2009) Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J Cell Biol 187:959–966
Cipolat S, Martins de Brito O, Dal Zilio B et al (2004) OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A 101:15927–15932
Frezza C, Cipolat S, Martins de Brito O et al (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126:177–189
Griparic L, Wel NN van der, Orozco IJ et al (2004) Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 279:18792–18798
Olichon A, Baricault L, Gas N et al (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278:7743–7746
Yoon Y, Krueger EW, Oswald BJ et al (2003) The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 23:5409–5420
Lee S, Jeong SY, Lim WC et al (2007) Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence. J Biol Chem 282:22977–22983
Stojanovski D, Koutsopoulos OS, Okamoto K et al (2004) Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology. J Cell Sci 117:1201–1210
James DI, Parone PA, Mattenberger Y et al (2003) hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 278:36373–36379
Pitts KR, McNiven MA, Yoon Y (2004) Mitochondria-specific function of the dynamin family protein DLP1 is mediated by its C-terminal domains. J Biol Chem 279:50286–50294
Zhu PP, Patterson A, Stadler J et al (2004) Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1. J Biol Chem 279:35967–35974
Mears JA, Lackner LL, Fang S et al (2011) Conformational changes in Dnm1 support a contractile mechanism for mitochondrial fission. Nat Struct Mol Biol 18:20–26
Elgass K, Pakay J, Ryan MT et al (2013) Recent advances into the understanding of mitochondrial fission. Biochim Biophys Acta 1833:150–161
Chang CR, Manlandro CM, Arnoult D et al (2010) A lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division. J Biol Chem 285:32494–32503
Karbowski M, Neutzner A, Youle RJ (2007) The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 178:71–84
Nakamura N, Kimura Y, Tokuda M et al (2006) MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7:1019–1022
Wang H, Song P, Du L et al (2011) Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J Biol Chem 286:11649–11658
Yonashiro R, Ishido S, Kyo S et al (2006) A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J 25:3618–3626
Wasiak S, Zunino R, McBride HM (2007) Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 177:439–450
Braschi E, Zunino R, McBride HM (2009) MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep 10:748–754
Cribbs JT, Strack S (2007) Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8:939–944
Wang W, Wang Y, Long J et al (2012) Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab 15:186–200
Taguchi N, Ishihara N, Jofuku A et al (2007) Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 282:11521–11529
Han XJ, Lu YF, Li SA et al (2008) CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol 182:573–585
Cereghetti GM, Stangherlin A, Martins de Brito O et al (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A 105:15803–15808
Frank S, Gaume B, Bergmann-Leitner ES et al (2001) The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1:515–525
Alirol E, James D, Huber D et al (2006) The mitochondrial fission protein hFis1 requires the endoplasmic reticulum gateway to induce apoptosis. Mol Biol Cell 17:4593–4605
Lee YJ, Jeong SY, Karbowski M et al (2004) Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15:5001–5011
Lamb JR, Tugendreich S, Hieter P (1995) Tetratrico peptide repeat interactions: to TPR or not to TPR? Trends Biochem Sci 20:257–259
Molina AJ, Wikstrom JD, Stiles L et al (2009) Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58:2303–2315
Stiles L, Shirihai OS (2012) Mitochondrial dynamics and morphology in beta-cells. Best Pract Res Clin Endocrinol Metab 26:725–738
Koch A, Yoon Y, Bonekamp NA et al (2005) A role for Fis1 in both mitochondrial and peroxisomal fission in mammalian cells. Mol Biol Cell 16:5077–5086
Yoon Y, Galloway CA, Jhun BS et al (2011) Mitochondrial dynamics in diabetes. Antioxid Redox Signal 14:439–457
Peng L, Men X, Zhang W et al (2012) Involvement of dynamin-related protein 1 in free fatty acid-induced INS-1-derived cell apoptosis. PLoS One 7:e49258
Peng L, Men X, Zhang W et al (2011) Dynamin-related protein 1 is implicated in endoplasmic reticulum stress-induced pancreatic β-cell apoptosis. Int J Mol Med 28:161–169
Men X, Wang H, Li M et al (2009) Dynamin-related protein 1 mediates high glucose induced pancreatic beta cell apoptosis. Int J Biochem Cell Biol 41:879–890
Einhaltung ethischer Richtlinien
Interessenkonflikt. S. Baltrusch, F. Reinhardt und M. Tiedge geben an, dass kein Interessenkonflikt besteht.
Der Beitrag enthält keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baltrusch, S., Reinhardt, F. & Tiedge, M. Mitochondrien als Kraftwerk der β-Zelle. Diabetologe 11, 231–242 (2015). https://doi.org/10.1007/s11428-014-1278-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-014-1278-5